Neogen Chemicals Limited Stock Price Today (NSE: NEOGEN)

Neogen Chemicals Limited

2302.407.90 (0.34%)
Market Closed

Fundamental Score

...

Neogen Chemicals Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Neogen Chemicals Limited share price today is 2302.40, down 0.34% on NSE/BSE as of 16 September 2026. Neogen Chemicals Limited (NEOGEN) is a Mid-cap company in the Specialty Chemicals sector with a market capitalisation of 6.30K (Cr). The 52-week high for NEOGEN share price is 2483.90 and the 52-week low is 966.70. At a P/E ratio of 173.24x, NEOGEN is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 3.58% and a debt-to-equity ratio of 1.63.

Neogen Chemicals Limited Share Price Chart — NSE/BSE Historical Performance

No data
High
2483.90
Low
2016.20
Volume
2.1L
Change
+1.38%

Neogen Chemicals Limited share price chart: 1.38% return over the past month. 52-week high ₹2483.90, 52-week low ₹966.70.

Neogen Chemicals Limited — Last 10 Trading Days

DateOpenHighLowCloseVolume
2302.002347.802202.902302.402.39L (Cr)
2381.002399.802234.302310.302.64L (Cr)
2390.002411.002274.402373.004.09L (Cr)
2240.002400.002231.002388.904.10L (Cr)
2216.002336.402216.002255.202.34L (Cr)
2223.202250.002175.702213.0088.41K (Cr)
2148.802244.202127.502207.101.78L (Cr)
2149.002172.602123.002137.9088.40K (Cr)
2136.402170.002114.002137.1069.59K (Cr)
2147.502166.302113.102136.4062.82K (Cr)

Neogen Chemicals Limited — Last 12 Months Price History

MonthOpenHighLowCloseChange
2245.302411.002113.102302.40+2.54%
2055.702483.901984.602201.20+7.08%
2030.002374.001920.002023.10-0.34%
1880.002090.001752.002024.90+7.71%
1650.001887.001547.001858.10+12.61%
1124.101720.001124.101637.50+45.67%
1360.001501.001101.201112.00-18.24%
1243.501488.901180.001464.30+17.76%
1184.201346.401090.501216.50+2.73%
1127.601199.00966.701184.20+5.02%
1442.601485.801118.901125.30-22.00%
1500.001557.201435.801442.60-3.83%

Returns & Performance

Poor

Return on Equity (ROE)

3.58%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

8.52%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

17.14%

Average operating profit margin over 5 years

Dividend Yield

0.04%

Annual dividend as % of current share price

Neogen Chemicals Limited Valuation Check

Poor

Price to Earnings (P/E)

173.24x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

31.95x

Average P/E of all peers in this sector

Market-cap Classification
Mid-cap
Balance of growth potential and stability.

Shareholding Pattern

Excellent

Promoter Holding

51.23%

% shares held by company founders/management

Poor

FII Holding

4.29%

% shares held by foreign institutional investors

Excellent

DII Holding

21.67%

% held by domestic mutual funds, LIC, banks

Poor

Promoter Pledged %

23.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Poor

Profit Growth (Quarterly YoY)

-100.00%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

34.04%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

20.70%

Compounded annual revenue growth over 5 years

Poor

EPS Growth (5-Year CAGR)

-4.12%

Earnings per share growth over 5 years

Poor

Net Profit Growth (5-Year CAGR)

-1.71%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Poor

Debt to Equity Ratio

1.63x

Total debt ÷ equity. Below 0.5 = financially healthy

Poor

Interest Coverage Ratio

1.55x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-1.54K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Neogen Chemicals Limited Fundamental Analysis & Valuation Benchmarking

Educational evaluation of NEOGEN across key market metrics for learning purposes.

Positive Indicators

5 factors identified

Strong Operating Margins (17.14%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (34.04%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (20.70% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Balanced Promoter Holding (51.23%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Strong Institutional Confidence (FII+DII: 25.96%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Risk Factors

11 factors identified

Below-Average Return on Equity (3.58%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Suboptimal ROCE (8.52%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Premium Valuation Risk (P/E: 173.24x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Price-to-Book Ratio (7.69x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Profit Decline Concern (-100.00%)

Observation: Significant year-over-year profit contraction observed.

Analysis: Declining profitability requires investigation into underlying causes.

Weak Earnings Growth (-4.12% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Stagnant Profit Growth (-1.71% CAGR)

Observation: Limited 5-year profit growth trajectory.

Analysis: Low profit growth may indicate scalability challenges or market maturity.

Elevated Debt Levels (D/E: 1.63)

Observation: High leverage increases financial risk and interest burden.

Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.

Weak Interest Coverage (1.55x)

Observation: Limited ability to service debt obligations from earnings.

Analysis: Low interest coverage raises concerns about financial stability.

Negative Free Cash Flow (₹-1543.77 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

High Share Pledging Risk (23.00%)

Observation: Significant promoter share pledging creates potential overhang.

Analysis: High pledging levels may create selling pressure during market downturns.

Neogen Chemicals Limited vs Specialty Chemicals Peers

Peer Comparison - Specialty Chemicals

Compare Neogen Chemicals Limited with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
18.9/100
2302
₹6303.97
173.2
Average
3.58%
Poor
8.52%
Poor
1.6
Average
-1.71%
Poor
20.70%
Excellent
0.04%
65.3/100
1574
₹160150.83
60.5
Average
23.79%
Excellent
29.92%
Excellent
0.0
Excellent
16.70%
Excellent
14.89%
Good
0.73%
42.9/100
4684
₹51519.60
84.1
Average
7.65%
Poor
10.87%
Average
0.3
Excellent
36.34%
Excellent
13.52%
Good
0.07%
62.7/100
8858
₹45441.54
57.5
Average
20.11%
Excellent
21.48%
Excellent
0.3
Excellent
20.84%
Excellent
22.95%
Excellent
0.20%
32.8/100
1665
₹22710.60
29.0
Average
9.81%
Poor
11.31%
Average
0.3
Excellent
-6.63%
Poor
12.59%
Good
0.44%
36.3/100
1633
₹21676.01
91.9
Average
9.38%
Poor
12.78%
Average
0.2
Excellent
0.00%
58.2/100
6282
₹18494.21
23.3
Average
11.47%
Average
14.24%
Average
0.0
Excellent
54.89%
Excellent
10.95%
Good
0.49%
38.7/100
498
₹18061.64
34.0
Average
7.25%
Poor
8.86%
Poor
0.8
Good
-4.35%
Poor
12.96%
Good
0.20%
52.2/100
3802
₹16458.86
25.6
Average
0.00%
Poor
14.04%
Average
0.0
Excellent
7.67%
Good
9.35%
Good
0.68%
62.09999999999999/100
5145
₹15774.57
36.0
Average
16.82%
Good
21.91%
Excellent
0.0
Excellent
28.23%
Excellent
15.86%
Excellent
0.21%
33.3/100
1225
₹13940.69
79.6
Average
5.50%
Poor
9.10%
Poor
0.5
Good
19.33%
Excellent
23.88%
Excellent
0.06%

Neogen Chemicals Limited PE Ratio History

Historical price-to-earnings ratio for NEOGEN — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202513.20₹1184.2089.7x
FY 202413.96₹2231.15159.8x
FY 202320.03₹1480.0573.9x
FY 202218.70₹1250.6566.9x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Neogen Chemicals Limited Dividend History

Annual cash dividends paid by NEOGEN — dividend yield 0.04%

Financial YearDividends Paid (₹ Cr)
FY 20255.28 Cr
FY 20247.48 Cr
FY 20236.86 Cr
FY 20225.25 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Neogen Chemicals Limited Quarterly Performance

Latest quarterly metrics for NEOGEN — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

34.04%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

-100.00%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

20.70%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

-1.71%

Compounded annual net profit growth over 5 years

Neogen Chemicals Limited Technical Indicators

SMA 50, SMA 200, RSI and volume signals for NEOGEN — calculated from daily price history

38RSI 14
Neutral — RSI 38

Momentum is balanced — neither overbought nor oversold.

SMA 50
2118
▲ Price above SMA 50 — Short-term bullish
SMA 200
1596
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
186K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Neogen Chemicals Limited Financial Statements

Annual income statement, balance sheet and cash flow for Neogen Chemicals Limited (NEOGEN) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Neogen Chemicals Limited

Loading latest quarterly results...

About NEOGEN (Neogen Chemicals Limited)

Neogen Chemicals Ltd is a prominent Indian manufacturer specializing in specialty chemicals, catering to a diverse range of industries. The company distinguishes itself through its... strong focus on producing niche chemical compounds that are essential building blocks for various applications. These specialized chemical products serve as key ingredients in the manufacturing of pharmaceuticals, agrochemicals, flavors, fragrances, polymers, and electronic chemicals. Neogen’s robust research and development capabilities enable them to create innovative solutions tailored to the specific needs of their clients, thereby establishing the company as a reliable and dependable supplier in the specialty chemical market. Neogen's commitment to product development ensures a steady stream of new and improved products. Neogen Chemicals Ltd excels in the production of a wide array of specialty organic chemicals that include bromine and chlorine compounds. Their bromine compounds consist of alkyl bromides, dibromoalkanes, and other derivatives essential for creating a variety of products. Their chlorine compounds consist of derivatives and other compounds. They are known for their precision in creating various compounds catering to specialized processes. Neogen's products are critical components in numerous applications. By specializing in these complex chemical families, Neogen ensures it meets stringent quality and purity demands, making them an attractive choice for companies that require high-performance chemicals. Neogen Chemicals Ltd has built a reputation for quality, reliability, and innovation. Its strategic focus on niche markets, combined with its strong manufacturing and research capabilities, has allowed Neogen to establish a prominent position in the specialty chemicals sector. The company is committed to sustainability and adheres to rigorous environmental standards in its production processes. Neogen continually invests in expanding its production capacity and enhancing its technological capabilities to meet growing market demand. The company's unwavering commitment to excellence positions them as a key player in the chemical industry, poised for continued growth and success.

Company Details

Symbol:NEOGEN
Industry:Specialty Chemicals
Sector:Specialty Chemicals

Key Leadership

Dr. Harin Haridas Kanani Ph.D.
MD & Executive Director
Mr. Shyamsunder Radeshyam Upadhyay
Director of Operations & Whole Time Director
Mr. Gopikrishnan Sarathy
Chief Financial Officer

NEOGEN Share Price: Frequently Asked Questions

What is the current share price of Neogen Chemicals Limited?

Neogen Chemicals Limited (NEOGEN) trades at ₹2302.40 on NSE and BSE. Market cap ₹6.30K (Cr). Educational data only.

What is the P/E ratio of Neogen Chemicals Limited?

Neogen Chemicals Limited has a P/E of 173.24x vs industry average 31.95x.

What is the Bull Run score for Neogen Chemicals Limited?

Neogen Chemicals Limited has a Bull Run score of 18.9/100 based on 25+ financial parameters.

Does Neogen Chemicals Limited pay dividends?

Neogen Chemicals Limited has a dividend yield of 0.04%. Past dividends don't guarantee future payments.

What is the ROE of Neogen Chemicals Limited?

Neogen Chemicals Limited has ROE of 3.58%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Neogen Chemicals Limited?

Neogen Chemicals Limited has debt-to-equity of 1.63.

Is Neogen Chemicals Limited a good investment?

Bull Run gives Neogen Chemicals Limited a score of 18.9/100. This is not investment advice — consult a SEBI-registered advisor.